Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Long-Acting Injection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00236587
What this trial is testing

A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 100
Large-scale testing (Phase 3)Active Not RecruitingNCT05546242
What this trial is testing

Improving HIV-1 Control in Africa with Long Acting Antiretrovirals

Who this might be right for
HIV-1-infection
MRC/UVRI and LSHTM Uganda Research Unit 540
Large-scale testing (Phase 3)Study completedNCT02946073
What this trial is testing

Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain

Who this might be right for
Chronic Lower Back PainChronic Pain
Braeburn Pharmaceuticals 1,053
Not applicableUnknownNCT05208541
What this trial is testing

Advancing Dignity, Health, and Optimism in Connection With Long Acting Injectables

Who this might be right for
HIV
Mazonson & Santas Inc. 200
Testing effectiveness (Phase 2)Study completedNCT03497676
What this trial is testing

More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 168
Not applicableStudy completedNCT00774085
What this trial is testing

An Observational Study to Assess Treatment & Outcomes Data in Patients Receiving Long-Acting Injectable Risperidone

Who this might be right for
Schizophrenia
Janssen Cilag N.V./S.A. 408
Large-scale testing (Phase 3)Active Not RecruitingNCT03164564
What this trial is testing

Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 3,224
Post-approval studies (Phase 4)Study completedNCT00299702
What this trial is testing

Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 355
Large-scale testing (Phase 3)Looking for participantsNCT05515770
What this trial is testing

The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir

Who this might be right for
HIV Infections
Evandro Chagas National Institute of Infectious Disease 1,200
Large-scale testing (Phase 3)Not Yet RecruitingNCT07623824
What this trial is testing

A Phase III Clinical Trial to Evaluate the Efficacy and Safety of Octreotide Long-acting Injection in Patients With Acromegaly

Who this might be right for
Diagnosed With Acromegaly, Currently in the Active Stage of the Disease
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 154
Early research (Phase 1)Looking for participantsNCT07269873
What this trial is testing

Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol

Who this might be right for
Healthy Adult Male and Female Volunteers
BioCorRx Pharmaceuticals Inc 30
Testing effectiveness (Phase 2)Study completedNCT02212886
What this trial is testing

Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 or 40 mg GA Depot in Subjects With RRMS

Who this might be right for
Multiple Sclerosis
Mapi Pharma Ltd. 25
Large-scale testing (Phase 3)Study completedNCT00132678
What this trial is testing

The Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood Episodes

Who this might be right for
Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 559
Large-scale testing (Phase 3)Study completedNCT02672111
What this trial is testing

Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder

Who this might be right for
Opioid Use Disorder
Braeburn Pharmaceuticals 228
Not applicableStudy completedNCT00294008
What this trial is testing

Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)

Who this might be right for
SchizophreniaTranquilizing AgentsMental Disorders+4 more
Janssen Korea, Ltd., Korea 230
Testing effectiveness (Phase 2)Looking for participantsNCT07185815
What this trial is testing

Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine

Who this might be right for
SchizophreniaBipolar I DisorderMajor Depressive Disorder
Mapi Pharma Ltd. 24
Not applicableStudy completedNCT05480046
What this trial is testing

Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse

Who this might be right for
Schizophrenia
Rovi Pharmaceuticals Laboratories 275
Large-scale testing (Phase 3)UnknownNCT03809143
What this trial is testing

Community Studies of Long Acting Buprenorphine (CoLAB)

Who this might be right for
Opioid Dependence
The University of New South Wales 100
Not applicableStudy completedNCT03130478
What this trial is testing

Predictors of Persistence in Patients With Schizophrenia Treated With Once-monthly Aripiprazole in Spain

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Europe Ltd 119
Not applicableUnknownNCT03130465
What this trial is testing

Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Europe Ltd 636
Next Page